Many drugs prescribed to older adults are studied in men, assuming women's biology doesn't differ. FDA should mandate sex and age data in clinical trials to assess efficacy accurately.
Alzheimer's drug Leqembi showed significant sex-based cognitive decline differences, raising concerns about its effectiveness for women, who form a substantial portion of older adults with Alzheimer's.
[
Collection
]
[
|
...
]